[
  {
    "title": "凯普生物(300639.SZ)：截至11月底已累计回购241.08万股",
    "href": "http://stock.jrj.com.cn/2022/11/30164737178399.shtml",
    "datetime": "2022-11-30 16:47:06",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司取得1项发明专利权",
    "href": "http://stock.jrj.com.cn/2022/11/03163537109849.shtml",
    "datetime": "2022-11-03 16:35:19",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：截至10月底已累计回购241.08万股",
    "href": "http://stock.jrj.com.cn/2022/10/31181437100541.shtml",
    "datetime": "2022-10-31 18:14:43",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：财务总监李庆辉完成减持1.01万股",
    "href": "http://stock.jrj.com.cn/2022/10/31181337100544.shtml",
    "datetime": "2022-10-31 18:13:20",
    "code": "300639"
  },
  {
    "title": "凯普生物2022年前三季度净利14.88亿同比增长130.04% 核酸检测需求增加",
    "href": "http://stock.jrj.com.cn/2022/10/21203237074537.shtml",
    "datetime": "2022-10-21 20:32:38",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)三季度净利5.1亿元 同比增长99.24%",
    "href": "http://stock.jrj.com.cn/2022/10/21185837074246.shtml",
    "datetime": "2022-10-21 18:58:57",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司取得换发的医疗器械生产许可证",
    "href": "http://stock.jrj.com.cn/2022/10/12180937050612.shtml",
    "datetime": "2022-10-12 18:09:38",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司以9079万元竞得潮州市2宗工业用地",
    "href": "http://stock.jrj.com.cn/2022/09/22185937014957.shtml",
    "datetime": "2022-09-22 18:59:20",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟斥0.5亿元-1亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/09/21192137012100.shtml",
    "datetime": "2022-09-21 19:21:11",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟以5000万元-1亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/09/21191637012046.shtml",
    "datetime": "2022-09-21 19:16:10",
    "code": "300639"
  },
  {
    "title": "凯普生物前三季净利润预计大增109%-124% 研发投入未“落伍”",
    "href": "http://stock.jrj.com.cn/2022/09/20101137007484.shtml",
    "datetime": "2022-09-20 10:11:00",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物涨4.8% 料前三季度净利同比翻倍",
    "href": "http://stock.jrj.com.cn/2022/09/19094237003681.shtml",
    "datetime": "2022-09-19 09:42:58",
    "code": "300639"
  },
  {
    "title": "凯普生物前三季净利大幅预增；赛力斯与重庆两江新区管理委员会订立战略协议",
    "href": "http://stock.jrj.com.cn/2022/09/19071837003240.shtml",
    "datetime": "2022-09-19 07:18:15",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)预计前三季度净利润增长108.68%-124.14%",
    "href": "http://stock.jrj.com.cn/2022/09/18163537002654.shtml",
    "datetime": "2022-09-18 16:35:32",
    "code": "300639"
  },
  {
    "title": "凯普生物：前三季度净利润同比预增109%-124%",
    "href": "http://stock.jrj.com.cn/2022/09/18162837002640.shtml",
    "datetime": "2022-09-18 16:28:03",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：财务总监李庆辉拟减持不超1.0137万股",
    "href": "http://stock.jrj.com.cn/2022/09/05154436973759.shtml",
    "datetime": "2022-09-05 15:44:03",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟使用不超4.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/08/31204536959694.shtml",
    "datetime": "2022-08-31 20:45:53",
    "code": "300639"
  },
  {
    "title": "凯普生物披露2022年半年报，实现营收28.43亿元",
    "href": "http://stock.jrj.com.cn/2022/08/16153736904295.shtml",
    "datetime": "2022-08-16 15:37:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2022年上半年净利9.78亿 同比增加150.19% 核酸检测需求增加",
    "href": "http://stock.jrj.com.cn/2022/08/15223236902092.shtml",
    "datetime": "2022-08-15 22:32:57",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)上半年净利9.78亿元，同比增长150.19%",
    "href": "http://stock.jrj.com.cn/2022/08/15182736901186.shtml",
    "datetime": "2022-08-15 18:27:36",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)及子公司取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/08/04175636870885.shtml",
    "datetime": "2022-08-04 17:56:06",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：取得发明专利权、为新冠核酸检测数据的智能审核及处置指引系统",
    "href": "http://stock.jrj.com.cn/2022/08/01211936860714.shtml",
    "datetime": "2022-08-01 21:19:30",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/07/05173736784001.shtml",
    "datetime": "2022-07-05 17:37:55",
    "code": "300639"
  },
  {
    "title": "凯普生物股东云南众合之减持25.12万股 套现约604.89万 2021年公司净利8.52亿",
    "href": "http://stock.jrj.com.cn/2022/06/27221136762790.shtml",
    "datetime": "2022-06-27 22:11:04",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：减持期届满 云南众合之已减持25.12万股",
    "href": "http://stock.jrj.com.cn/2022/06/27190336762198.shtml",
    "datetime": "2022-06-27 19:03:37",
    "code": "300639"
  },
  {
    "title": "凯普生物：2022上半年净利润同比增长117.38%-142.95%",
    "href": "http://stock.jrj.com.cn/2022/06/22143636749400.shtml",
    "datetime": "2022-06-22 14:36:51",
    "code": "300639"
  },
  {
    "title": "凯普生物：预计2022年半年度盈利8.50亿至9.50亿元",
    "href": "http://stock.jrj.com.cn/2022/06/22113936749007.shtml",
    "datetime": "2022-06-22 11:39:14",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨超7% 上半年净利预增超117% 核酸检测需求增加",
    "href": "http://stock.jrj.com.cn/2022/06/22094336748595.shtml",
    "datetime": "2022-06-22 09:43:10",
    "code": "300639"
  },
  {
    "title": "格隆汇公告精选︱凯普生物上半年净利润预增117.38%-142.95%；中兴通讯拟终止发行股份募集配套资金",
    "href": "http://stock.jrj.com.cn/2022/06/22000236748009.shtml",
    "datetime": "2022-06-22 00:02:28",
    "code": "300639"
  },
  {
    "title": "凯普生物2022年上半年预计净利8.5亿-9.5亿同比增长117%-143% 核酸检测需求增加",
    "href": "http://stock.jrj.com.cn/2022/06/21215236747801.shtml",
    "datetime": "2022-06-21 21:52:51",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：上半年净利润预增117.38%-142.95%",
    "href": "http://stock.jrj.com.cn/2022/06/21200836747482.shtml",
    "datetime": "2022-06-21 20:08:52",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)及子公司获得授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2022/06/21192636747318.shtml",
    "datetime": "2022-06-21 19:26:56",
    "code": "300639"
  },
  {
    "title": "凯普生物：上半年预盈8.5亿元-9.5亿元 同比增117%-143%",
    "href": "http://stock.jrj.com.cn/2022/06/21191836747290.shtml",
    "datetime": "2022-06-21 19:18:13",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司取得医疗器械注册证书",
    "href": "http://stock.jrj.com.cn/2022/06/09194136717038.shtml",
    "datetime": "2022-06-09 19:41:30",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：凯普化学拟以3000万元参投达晨财智基金",
    "href": "http://stock.jrj.com.cn/2022/06/02150936700205.shtml",
    "datetime": "2022-06-02 15:09:55",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：取得发明专利、为一种用于检测病原体的多重PCR引物和探针组合及其应用",
    "href": "http://stock.jrj.com.cn/2022/05/26180736681832.shtml",
    "datetime": "2022-05-26 18:07:55",
    "code": "300639"
  },
  {
    "title": "凯普生物：猴痘病毒核酸检测试剂盒等七项产品获得CE证书",
    "href": "http://stock.jrj.com.cn/2022/05/25195836678706.shtml",
    "datetime": "2022-05-25 19:58:36",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：七项产品取得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/25193636678623.shtml",
    "datetime": "2022-05-25 19:36:24",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨超4% 公司表示具备猴痘病毒的实验室检测能力",
    "href": "http://stock.jrj.com.cn/2022/05/23110436669554.shtml",
    "datetime": "2022-05-23 11:04:29",
    "code": "300639"
  },
  {
    "title": "凯普生物拟投资建设凯普医学科学园 预计总投资约15.12亿",
    "href": "http://stock.jrj.com.cn/2022/05/11221136637203.shtml",
    "datetime": "2022-05-11 22:11:48",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟15.12亿元投建凯普医学科学园",
    "href": "http://stock.jrj.com.cn/2022/05/11203236636277.shtml",
    "datetime": "2022-05-11 20:32:58",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟投资15.12亿元建凯普医学科学园",
    "href": "http://stock.jrj.com.cn/2022/05/11201736636211.shtml",
    "datetime": "2022-05-11 20:17:52",
    "code": "300639"
  },
  {
    "title": "【晚间公告全知道】凯普生物拟中选广东联盟新冠试剂耗材接续带量采购",
    "href": "http://stock.jrj.com.cn/2022/05/09222836611626.shtml",
    "datetime": "2022-05-09 22:28:06",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：“新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)”等产品拟中选相关带量采购",
    "href": "http://stock.jrj.com.cn/2022/05/09192736609114.shtml",
    "datetime": "2022-05-09 19:27:26",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟中选广东联盟新冠试剂耗材接续带量采购",
    "href": "http://stock.jrj.com.cn/2022/05/09192336609098.shtml",
    "datetime": "2022-05-09 19:23:40",
    "code": "300639"
  },
  {
    "title": "凯普生物2022年第一季度净利5亿同比增长190.64% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2022/05/03135036543012.shtml",
    "datetime": "2022-05-03 13:50:53",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)一季度净利润5亿元 同比增长190.64%",
    "href": "http://stock.jrj.com.cn/2022/04/26191636477693.shtml",
    "datetime": "2022-04-26 19:16:47",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)2021年度权益分派10转5派3.5元 股权登记日为4月28日",
    "href": "http://stock.jrj.com.cn/2022/04/20201236412255.shtml",
    "datetime": "2022-04-20 20:12:06",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：全资子公司取得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/04/11185136306151.shtml",
    "datetime": "2022-04-11 18:51:15",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨4% 料一季度净利同比增109.38%-144.27%",
    "href": "http://stock.jrj.com.cn/2022/04/01095836245373.shtml",
    "datetime": "2022-04-01 09:58:47",
    "code": "300639"
  },
  {
    "title": "凯普生物2022年第一季度预计净利约3.6亿-4.2亿 同比增加109%-144% 公司业务快速发展",
    "href": "http://stock.jrj.com.cn/2022/03/31211036241913.shtml",
    "datetime": "2022-03-31 21:10:47",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：一季度净利预增109.38%-144.27%",
    "href": "http://stock.jrj.com.cn/2022/03/31182836241175.shtml",
    "datetime": "2022-03-31 18:28:37",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：云南众合之减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/03/28185135913521.shtml",
    "datetime": "2022-03-28 18:51:41",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年净利8.52亿同比增长134.97% 董事长黄伟雄薪酬30万",
    "href": "http://stock.jrj.com.cn/2022/03/26051335220900.shtml",
    "datetime": "2022-03-26 05:13:03",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟使用不超8亿元闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/03/25212235155938.shtml",
    "datetime": "2022-03-25 21:22:45",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：2021年净利增134.97%至8.52亿元 拟10转5派3.5元",
    "href": "http://stock.jrj.com.cn/2022/03/25192535138500.shtml",
    "datetime": "2022-03-25 19:25:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：凯普智造取得医疗器械生产许可证",
    "href": "http://stock.jrj.com.cn/2022/03/18210834847210.shtml",
    "datetime": "2022-03-18 21:08:35",
    "code": "300639"
  },
  {
    "title": "凯普生物：全资子公司拟1.66亿元参设大健康产业基金",
    "href": "http://stock.jrj.com.cn/2022/03/07201434538738.shtml",
    "datetime": "2022-03-07 20:14:45",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟与专业投资机构共同发起设立大健康产业基金",
    "href": "http://stock.jrj.com.cn/2022/03/07195934538700.shtml",
    "datetime": "2022-03-07 19:59:38",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)及子公司获得授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2022/02/21193434423601.shtml",
    "datetime": "2022-02-21 19:34:24",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：获得授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2022/02/17184334382729.shtml",
    "datetime": "2022-02-17 18:43:19",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：全资子公司获得1项澳大利亚专利证书",
    "href": "http://stock.jrj.com.cn/2022/01/18191434170861.shtml",
    "datetime": "2022-01-18 19:14:54",
    "code": "300639"
  },
  {
    "title": "A股异动丨凯普生物涨4.71% 中标建设第三方医学检验实验室项目投资合作方选取项目",
    "href": "http://stock.jrj.com.cn/2022/01/12135934149571.shtml",
    "datetime": "2022-01-12 13:59:30",
    "code": "300639"
  },
  {
    "title": "凯普生物：中标建设第三方医学检验实验室项目投资合作方选取项目",
    "href": "http://stock.jrj.com.cn/2022/01/11202434147461.shtml",
    "datetime": "2022-01-11 20:24:36",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司中标佛山市南海区建设第三方医学检验实验室项目投资合作方选取项目",
    "href": "http://stock.jrj.com.cn/2022/01/11195634147359.shtml",
    "datetime": "2022-01-11 19:56:47",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：全资子公司获得美国、俄罗斯专利证书",
    "href": "http://stock.jrj.com.cn/2022/01/05202534126270.shtml",
    "datetime": "2022-01-05 20:25:30",
    "code": "300639"
  },
  {
    "title": "凯普生物股东云南众合之质押390万股 用于业务需要",
    "href": "http://stock.jrj.com.cn/2021/12/28205034077904.shtml",
    "datetime": "2021-12-28 20:50:45",
    "code": "300639"
  },
  {
    "title": "凯普生物股东云南众合之质押195万股 用于业务需要",
    "href": "http://stock.jrj.com.cn/2021/12/20215034036849.shtml",
    "datetime": "2021-12-20 21:50:41",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年预计净利8亿-8.6亿增长120.59%-137.14% 加强市场拓展",
    "href": "http://stock.jrj.com.cn/2021/12/10051133992056.shtml",
    "datetime": "2021-12-10 05:11:10",
    "code": "300639"
  },
  {
    "title": "凯普生物业绩预告：检测需求不减 净利润预增120%-137%",
    "href": "http://stock.jrj.com.cn/2021/12/08091934040138.shtml",
    "datetime": "2021-12-08 09:19:00",
    "code": "300639"
  },
  {
    "title": "凯普生物业绩预告：检测需求不减 净利润预增120%-137%",
    "href": "http://stock.jrj.com.cn/2021/12/08091933984027.shtml",
    "datetime": "2021-12-08 09:19:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：预计2021年净利同比增长121%-137%",
    "href": "http://stock.jrj.com.cn/2021/12/07211933981705.shtml",
    "datetime": "2021-12-07 21:19:23",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)2021年度预盈8亿-8.6亿元 同比增长120.59%-137.14%",
    "href": "http://stock.jrj.com.cn/2021/12/07195633981311.shtml",
    "datetime": "2021-12-07 19:56:38",
    "code": "300639"
  },
  {
    "title": "凯普生物控股子公司中标泸州卫生健康委员会全民健康工程妇幼疾病检测服务采购项目 中标价4605.91万",
    "href": "http://stock.jrj.com.cn/2021/12/06213133975568.shtml",
    "datetime": "2021-12-06 21:31:55",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司产品可有效涵盖检测本次的新型变异株B.1.1.529(Omicron“奥密克戎”)",
    "href": "http://stock.jrj.com.cn/2021/11/29144433937731.shtml",
    "datetime": "2021-11-29 14:44:28",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司获授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2021/11/25190233919958.shtml",
    "datetime": "2021-11-25 19:02:58",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟以4000万元参与投资广发信德创业投资基金",
    "href": "http://stock.jrj.com.cn/2021/11/08205833824525.shtml",
    "datetime": "2021-11-08 20:58:05",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年前三季度净利6.47亿元 同比净利增加136.71%",
    "href": "http://stock.jrj.com.cn/2021/10/19174933717568.shtml",
    "datetime": "2021-10-19 17:49:37",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)第三季度净利润2.56亿元 同比增长77.33%",
    "href": "http://stock.jrj.com.cn/2021/10/19172633717107.shtml",
    "datetime": "2021-10-19 17:26:51",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：被拟认定为2021年国家技术创新示范企业",
    "href": "http://stock.jrj.com.cn/2021/10/14121533689875.shtml",
    "datetime": "2021-10-14 12:15:16",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：重庆凯普医学检验所拟以1174.03万元购买房产",
    "href": "http://stock.jrj.com.cn/2021/10/13222633687073.shtml",
    "datetime": "2021-10-13 22:26:04",
    "code": "300639"
  },
  {
    "title": "凯普生物：检测新型冠状病毒的引物探针组合及其应用被授予发明专利权",
    "href": "http://stock.jrj.com.cn/2021/09/28213033532648.shtml",
    "datetime": "2021-09-28 21:30:49",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)及子公司获得一项发明专利",
    "href": "http://stock.jrj.com.cn/2021/09/28203633532357.shtml",
    "datetime": "2021-09-28 20:36:34",
    "code": "300639"
  },
  {
    "title": "凯普生物前三季业绩预增123-145% 研发投入增七成 盈利能力在提升",
    "href": "http://stock.jrj.com.cn/2021/09/08084633402501.shtml",
    "datetime": "2021-09-08 08:46:00",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨5% 前三季度净利预增123.20%-145.16%",
    "href": "http://stock.jrj.com.cn/2021/09/07103333397218.shtml",
    "datetime": "2021-09-07 10:33:31",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年前三季度预计净利6.1亿–6.7亿 同比增长123%–145%",
    "href": "http://stock.jrj.com.cn/2021/09/06193733394167.shtml",
    "datetime": "2021-09-06 19:37:25",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司业务取得较快增长 前三季度净利预盈6.1亿至6.7亿元",
    "href": "http://stock.jrj.com.cn/2021/09/06171733393212.shtml",
    "datetime": "2021-09-06 17:17:59",
    "code": "300639"
  },
  {
    "title": "凯普生物：第三季度净利同比预增52%-93%",
    "href": "http://stock.jrj.com.cn/2021/09/06155733392259.shtml",
    "datetime": "2021-09-06 15:57:28",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)前三季度净利预增123.20%-145.16%",
    "href": "http://stock.jrj.com.cn/2021/09/06155533392244.shtml",
    "datetime": "2021-09-06 15:55:34",
    "code": "300639"
  },
  {
    "title": "凯普生物：潮州全资子公司有入选第二批专精特新“小巨人”企业",
    "href": "http://stock.jrj.com.cn/2021/09/01152633367697.shtml",
    "datetime": "2021-09-01 15:26:20",
    "code": "300639"
  },
  {
    "title": "凯普生物股东云南众合之质押200万股 用于生产经营",
    "href": "http://stock.jrj.com.cn/2021/08/25221333319361.shtml",
    "datetime": "2021-08-25 22:13:33",
    "code": "300639"
  },
  {
    "title": "凯普生物医学检验服务扩张净利3.9亿 研发投入四连增推进核酸诊断全覆盖",
    "href": "http://stock.jrj.com.cn/2021/08/12074833241001.shtml",
    "datetime": "2021-08-12 07:48:40",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年半年度净利3.91亿元 同比净利增加203.15%",
    "href": "http://stock.jrj.com.cn/2021/08/11114233236511.shtml",
    "datetime": "2021-08-11 11:42:32",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟通过凯普健康管理开展妇女儿童医院建设项目",
    "href": "http://stock.jrj.com.cn/2021/08/10193033233224.shtml",
    "datetime": "2021-08-10 19:30:38",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：上半年净利增203.15%至3.91亿元",
    "href": "http://stock.jrj.com.cn/2021/08/10192233233202.shtml",
    "datetime": "2021-08-10 19:22:02",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：获得一项发明专利",
    "href": "http://stock.jrj.com.cn/2021/08/03165033195370.shtml",
    "datetime": "2021-08-03 16:50:59",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：全资子公司获一项发明专利",
    "href": "http://stock.jrj.com.cn/2021/07/26181033153193.shtml",
    "datetime": "2021-07-26 18:10:53",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：完成控股子公司海口凯普医学检验实验室的设立",
    "href": "http://stock.jrj.com.cn/2021/07/18180033112648.shtml",
    "datetime": "2021-07-18 18:00:25",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟通过控股子公司新设部分第三方医学实验室和司法鉴定所",
    "href": "http://stock.jrj.com.cn/2021/07/06191733054187.shtml",
    "datetime": "2021-07-06 19:17:53",
    "code": "300639"
  },
  {
    "title": "新药获专利 业绩股价齐飞 凯普生物成长动力强",
    "href": "http://stock.jrj.com.cn/2021/07/01080033026299.shtml",
    "datetime": "2021-07-01 08:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：深圳凯鹏医学检验实验室取得营业执照",
    "href": "http://stock.jrj.com.cn/2021/06/29190633017121.shtml",
    "datetime": "2021-06-29 19:06:58",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：取得一项发明专利",
    "href": "http://stock.jrj.com.cn/2021/06/29190433017116.shtml",
    "datetime": "2021-06-29 19:04:44",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司香港分子病理检验中心拟推员工股权激励计划",
    "href": "http://stock.jrj.com.cn/2021/06/21192032970956.shtml",
    "datetime": "2021-06-21 19:20:34",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：获授予1项发明专利权",
    "href": "http://stock.jrj.com.cn/2021/06/17192932949096.shtml",
    "datetime": "2021-06-17 19:29:30",
    "code": "300639"
  },
  {
    "title": "凯普生物：近期公司暂无回购股份计划",
    "href": "http://stock.jrj.com.cn/2021/06/15184132935927.shtml",
    "datetime": "2021-06-15 18:41:15",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：公司及子公司获得两项发明专利",
    "href": "http://stock.jrj.com.cn/2021/06/15182232935794.shtml",
    "datetime": "2021-06-15 18:22:20",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：向174名激励对象授予392.055万份股票期权",
    "href": "http://stock.jrj.com.cn/2021/06/07194332888429.shtml",
    "datetime": "2021-06-07 19:43:10",
    "code": "300639"
  },
  {
    "title": "凯普生物：目前公司核酸检测试剂日产能20万人份",
    "href": "http://stock.jrj.com.cn/2021/06/01204332859112.shtml",
    "datetime": "2021-06-01 20:43:54",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司在妇幼健康、出生缺陷领域已开发系列核酸检测产品",
    "href": "http://stock.jrj.com.cn/2021/06/01184932858495.shtml",
    "datetime": "2021-06-01 18:49:28",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨超6% 上半年净利润同比预增148.09%-186.85%",
    "href": "http://stock.jrj.com.cn/2021/05/31141632848845.shtml",
    "datetime": "2021-05-31 14:16:39",
    "code": "300639"
  },
  {
    "title": "凯普生物：预计2021上半年净利润同比增长148%-186%",
    "href": "http://stock.jrj.com.cn/2021/05/28110432834345.shtml",
    "datetime": "2021-05-28 11:04:39",
    "code": "300639"
  },
  {
    "title": "凯普生物上半年净利润预增1.4-1.8倍 “新冠业务”放量 两大主业大增",
    "href": "http://stock.jrj.com.cn/2021/05/28081832833941.shtml",
    "datetime": "2021-05-28 08:18:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年上半年预计净利3.2亿-3.7亿增长148%-186% 检测服务收入增长",
    "href": "http://stock.jrj.com.cn/2021/05/27220632832238.shtml",
    "datetime": "2021-05-27 22:06:23",
    "code": "300639"
  },
  {
    "title": "凯普生物：目前公司新冠核酸检测试剂盒已出口部分国家和地区",
    "href": "http://stock.jrj.com.cn/2021/05/27185732831307.shtml",
    "datetime": "2021-05-27 18:57:22",
    "code": "300639"
  },
  {
    "title": "【公告抢先看】晚间重要公告：舍得酒业多名董事、监事集体辞职、凯普生物预计上半年净利同比增长186.85%",
    "href": "http://stock.jrj.com.cn/2021/05/27181832831023.shtml",
    "datetime": "2021-05-27 18:18:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：2021年半年度业绩预告 净利润同比上升",
    "href": "http://stock.jrj.com.cn/2021/05/27160632830364.shtml",
    "datetime": "2021-05-27 16:06:02",
    "code": "300639"
  },
  {
    "title": "凯普生物业绩预告：预计上半年净利同比增长148.09%-186.85%",
    "href": "http://stock.jrj.com.cn/2021/05/27155932829994.shtml",
    "datetime": "2021-05-27 15:59:02",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)半年度净利润预增148.09%-186.85%",
    "href": "http://stock.jrj.com.cn/2021/05/27155832829993.shtml",
    "datetime": "2021-05-27 15:58:13",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨逾8% 全资子公司获得韩国、日本发明专利授权通知书",
    "href": "http://stock.jrj.com.cn/2021/05/20134332786800.shtml",
    "datetime": "2021-05-20 13:43:46",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639)：2020年年度权益分派实施，每10股派发现金红利2.5元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/20042932784178.shtml",
    "datetime": "2021-05-20 04:29:11",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：全资子公司获得韩国、日本发明专利授权通知书",
    "href": "http://stock.jrj.com.cn/2021/05/19213132783454.shtml",
    "datetime": "2021-05-19 21:31:49",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)2020年度权益分派10转2.514125派2.514125元 股权登记日为5月27日",
    "href": "http://stock.jrj.com.cn/2021/05/19212532783438.shtml",
    "datetime": "2021-05-19 21:25:29",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司拟购买潮州相关土地使用权及已建设的工业厂房",
    "href": "http://stock.jrj.com.cn/2021/05/10203532731640.shtml",
    "datetime": "2021-05-10 20:35:46",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟推330万份2021年股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2021/05/10203332731632.shtml",
    "datetime": "2021-05-10 20:33:45",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：减持期满 云南众合之已累计减持359.01万股",
    "href": "http://stock.jrj.com.cn/2021/05/06213732703473.shtml",
    "datetime": "2021-05-06 21:37:27",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司新冠试剂正在启动多国的注册认证工作",
    "href": "http://stock.jrj.com.cn/2021/04/21160632416518.shtml",
    "datetime": "2021-04-21 16:06:48",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年第一季度净利增长771% 医学实验室业务规模扩大",
    "href": "http://stock.jrj.com.cn/2021/04/20231132412556.shtml",
    "datetime": "2021-04-20 23:11:41",
    "code": "300639"
  },
  {
    "title": "医疗板块持续拉升，凯普生物一季报利润暴涨8倍涨超7.6%",
    "href": "http://stock.jrj.com.cn/2021/04/20140132409330.shtml",
    "datetime": "2021-04-20 14:01:24",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)一季度净利润升771.05%至1.72亿元",
    "href": "http://stock.jrj.com.cn/2021/04/19205732404207.shtml",
    "datetime": "2021-04-19 20:57:37",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司持续加强产能建设以满足日益增长的市场需求并启动了MDSAP五国体系认证项目",
    "href": "http://stock.jrj.com.cn/2021/04/16163332386971.shtml",
    "datetime": "2021-04-16 16:33:59",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司是宫颈癌早期筛查HPV检测的国内龙头企业",
    "href": "http://stock.jrj.com.cn/2021/04/16162832386922.shtml",
    "datetime": "2021-04-16 16:28:59",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年净利3.63亿同比增长146.22% 总经理管乔中薪酬187.04万",
    "href": "http://stock.jrj.com.cn/2021/04/13132332364115.shtml",
    "datetime": "2021-04-13 13:23:16",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)2020年度净利润升146.22%至3.63亿元 拟10转2.5派2.5元",
    "href": "http://stock.jrj.com.cn/2021/04/12215032359907.shtml",
    "datetime": "2021-04-12 21:50:45",
    "code": "300639"
  },
  {
    "title": "核酸检测业务助力，凯普生物2020年净利润同比增长140%",
    "href": "http://stock.jrj.com.cn/2021/04/02114232269586.shtml",
    "datetime": "2021-04-02 11:42:41",
    "code": "300639"
  },
  {
    "title": "凯普生物2021年第一季度预计净利增长584%-787% 业务取得较快增长",
    "href": "http://stock.jrj.com.cn/2021/04/02093832268843.shtml",
    "datetime": "2021-04-02 09:38:37",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年度净利3.5亿增长140% 核酸检测产品销售快速提升",
    "href": "http://stock.jrj.com.cn/2021/04/02091332268654.shtml",
    "datetime": "2021-04-02 09:13:11",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)一季度净利润预增583.91%-786.55%",
    "href": "http://stock.jrj.com.cn/2021/04/01201432264651.shtml",
    "datetime": "2021-04-01 20:14:03",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)业绩快报：2020年度净利润升139.8%至3.53亿元",
    "href": "http://stock.jrj.com.cn/2021/04/01201132264643.shtml",
    "datetime": "2021-04-01 20:11:34",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)截至3月底已累计回购133.42万股",
    "href": "http://stock.jrj.com.cn/2021/04/01165832263651.shtml",
    "datetime": "2021-04-01 16:58:59",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：约2185.31万股限售股3月16日解禁",
    "href": "http://stock.jrj.com.cn/2021/03/10183432104823.shtml",
    "datetime": "2021-03-10 18:34:27",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)截止2月底累计回购5000.1万元股份",
    "href": "http://stock.jrj.com.cn/2021/03/01160932050511.shtml",
    "datetime": "2021-03-01 16:09:40",
    "code": "300639"
  },
  {
    "title": "凯普生物：国内领先的核酸分子诊断产品提供商 2020年业绩预增117.26%-166.82%",
    "href": "http://stock.jrj.com.cn/2021/02/20141031997408.shtml",
    "datetime": "2021-02-20 14:10:02",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司目前研发生产的核酸检测试剂盒均可用于公司旗下医学检验所的检测项目",
    "href": "http://stock.jrj.com.cn/2021/02/04183231850010.shtml",
    "datetime": "2021-02-04 18:32:35",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)获实控人王建瑜增持24万股",
    "href": "http://stock.jrj.com.cn/2021/01/21190131739059.shtml",
    "datetime": "2021-01-21 19:01:10",
    "code": "300639"
  },
  {
    "title": "【龙虎榜】凯普生物1月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/21180131737970.shtml",
    "datetime": "2021-01-21 18:01:40",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司在石家庄设立的石家庄凯普医学检验实验室有限公司目前还在建设阶段",
    "href": "http://stock.jrj.com.cn/2021/01/13180431685359.shtml",
    "datetime": "2021-01-13 18:04:47",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟以2220万元对湖南友哲进行投资",
    "href": "http://stock.jrj.com.cn/2021/01/12183131677642.shtml",
    "datetime": "2021-01-12 18:31:18",
    "code": "300639"
  },
  {
    "title": "[凯普生物]热烈祝贺凯普生物创始人王建瑜当选香港潮属社团总会会长",
    "href": "http://stock.jrj.com.cn/2021/01/11000031675609.shtml",
    "datetime": "2021-01-11 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司可为各级医疗机构提供PCR实验室整体解决方案",
    "href": "http://stock.jrj.com.cn/2021/01/07091831645875.shtml",
    "datetime": "2021-01-07 09:18:40",
    "code": "300639"
  },
  {
    "title": "[凯普生物]可鉴别新冠变异病毒!凯普两款新冠病毒核酸试剂盒检测范围覆盖突变毒株",
    "href": "http://stock.jrj.com.cn/2021/01/07000031675610.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：子公司拟896.26万元向宁夏银基公司购买“银川市金凤区银基大厦B座301室”房产",
    "href": "http://stock.jrj.com.cn/2021/01/05172231635105.shtml",
    "datetime": "2021-01-05 17:22:44",
    "code": "300639"
  },
  {
    "title": "[凯普生物]打好2021年抗疫第一战 凯普沈阳元旦全面投入战疫行动",
    "href": "http://stock.jrj.com.cn/2021/01/05000031635688.shtml",
    "datetime": "2021-01-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年预计净利3.2亿-3.93亿 核酸检测试剂业务取得较快发展",
    "href": "http://stock.jrj.com.cn/2020/12/29193631597057.shtml",
    "datetime": "2020-12-29 19:36:27",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨5.7% 料2020年净利同比增117.26%至166.82%",
    "href": "http://stock.jrj.com.cn/2020/12/29133031594623.shtml",
    "datetime": "2020-12-29 13:30:55",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物中选新冠核酸集采 降本增效支援疫情防控",
    "href": "http://stock.jrj.com.cn/2020/12/29000031593596.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]香港特首林郑月娥一行到访香港凯普 团结一心 携手抗疫",
    "href": "http://stock.jrj.com.cn/2020/12/29000031594944.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：2020年度净利预增117.26%-166.82%",
    "href": "http://stock.jrj.com.cn/2020/12/28203531588281.shtml",
    "datetime": "2020-12-28 20:35:43",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物参与广东省企联合基金签约仪式 正式设立凯普联合基金",
    "href": "http://stock.jrj.com.cn/2020/12/24000031561111.shtml",
    "datetime": "2020-12-24 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]再创佳绩!凯普生物荣获中国上市公司“金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2020/12/24000031562629.shtml",
    "datetime": "2020-12-24 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]屡获殊荣!凯普生物荣获中国上市公司口碑榜“生物医药产业最具成长上市公司奖”",
    "href": "http://stock.jrj.com.cn/2020/12/24000031562632.shtml",
    "datetime": "2020-12-24 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)获得政府补助1563万元",
    "href": "http://stock.jrj.com.cn/2020/12/22194431547000.shtml",
    "datetime": "2020-12-22 19:44:35",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：副总经理谢龙旭累计减持4.8万股 减持计划已实施完毕",
    "href": "http://stock.jrj.com.cn/2020/12/14200831488993.shtml",
    "datetime": "2020-12-14 20:08:48",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：云南众合之持股比例降至6.27%",
    "href": "http://stock.jrj.com.cn/2020/12/14200731488992.shtml",
    "datetime": "2020-12-14 20:07:42",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：股东云南众合之减持1.09%股份",
    "href": "http://stock.jrj.com.cn/2020/12/11194331466765.shtml",
    "datetime": "2020-12-11 19:43:13",
    "code": "300639"
  },
  {
    "title": "凯普生物实际控制人王建瑜增持20万股 耗资约689.8万元",
    "href": "http://stock.jrj.com.cn/2020/12/10213231459273.shtml",
    "datetime": "2020-12-10 21:32:58",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：实控人王建瑜增持20万股",
    "href": "http://stock.jrj.com.cn/2020/12/10202331458996.shtml",
    "datetime": "2020-12-10 20:23:16",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：凯普医药变更医疗器械生产许可证",
    "href": "http://stock.jrj.com.cn/2020/12/09185031450672.shtml",
    "datetime": "2020-12-09 18:50:31",
    "code": "300639"
  },
  {
    "title": "凯普生物实际控制人王建瑜增持17万股 耗资约572.39万元",
    "href": "http://stock.jrj.com.cn/2020/12/08215931443367.shtml",
    "datetime": "2020-12-08 21:59:02",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)首次回购29.01万股 涉资1079.93万元",
    "href": "http://stock.jrj.com.cn/2020/12/08191231442120.shtml",
    "datetime": "2020-12-08 19:12:31",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：董事、常务副总经理王建瑜已增持17万股",
    "href": "http://stock.jrj.com.cn/2020/12/08191131442106.shtml",
    "datetime": "2020-12-08 19:11:49",
    "code": "300639"
  },
  {
    "title": "凯普生物将花不超1亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2020/12/02212231394726.shtml",
    "datetime": "2020-12-02 21:22:31",
    "code": "300639"
  },
  {
    "title": "A股异动丨凯普生物(300639.SZ)涨约4% 拟回购5000万元-1亿元股份 回购价不超39元/股",
    "href": "http://stock.jrj.com.cn/2020/12/02094631390749.shtml",
    "datetime": "2020-12-02 09:46:58",
    "code": "300639"
  },
  {
    "title": "凯普生物实际控制人王建瑜增持20万股 耗资约646.2万元",
    "href": "http://stock.jrj.com.cn/2020/11/26190831354622.shtml",
    "datetime": "2020-11-26 19:08:21",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：实控人、董事王建瑜增持20万股",
    "href": "http://stock.jrj.com.cn/2020/11/26171631353548.shtml",
    "datetime": "2020-11-26 17:16:04",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：新生儿血液收集卡获医疗器械注册证书",
    "href": "http://stock.jrj.com.cn/2020/11/25161431346473.shtml",
    "datetime": "2020-11-25 16:14:52",
    "code": "300639"
  },
  {
    "title": "凯普生物常务副总经理王建瑜增持20万股 耗资约696.8万元",
    "href": "http://stock.jrj.com.cn/2020/11/19215531318737.shtml",
    "datetime": "2020-11-19 21:55:06",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)获实控人王建瑜增持20万股",
    "href": "http://stock.jrj.com.cn/2020/11/19180731317614.shtml",
    "datetime": "2020-11-19 18:07:59",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物与中科院深圳先进研究院签约成立精准医疗联合实验室",
    "href": "http://stock.jrj.com.cn/2020/11/13000031274524.shtml",
    "datetime": "2020-11-13 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物荣登2020年福布斯中国上市公司潜力企业榜",
    "href": "http://stock.jrj.com.cn/2020/11/12000031269467.shtml",
    "datetime": "2020-11-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物全自动核酸提取仪荣获2020年潮州首届“市长杯”工业设计大赛金奖",
    "href": "http://stock.jrj.com.cn/2020/11/12000031269470.shtml",
    "datetime": "2020-11-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]广州凯普医学检验所通过ISO15189医学实验室质量与能力认可",
    "href": "http://stock.jrj.com.cn/2020/11/12000031269466.shtml",
    "datetime": "2020-11-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物股东王建瑜增持20万股 耗资约794.6万元",
    "href": "http://stock.jrj.com.cn/2020/11/10185231252602.shtml",
    "datetime": "2020-11-10 18:52:26",
    "code": "300639"
  },
  {
    "title": "[凯普生物]新品上市 - 凯普华法林基因检测试剂盒获批上市",
    "href": "http://stock.jrj.com.cn/2020/11/05000031223185.shtml",
    "datetime": "2020-11-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：持股5%以上股东云南众合之拟减持不超2.64%公司股份",
    "href": "http://stock.jrj.com.cn/2020/11/02191131202225.shtml",
    "datetime": "2020-11-02 19:11:53",
    "code": "300639"
  },
  {
    "title": "凯普生物：前三季度净利润同比增长160% 重磅品种放量在即",
    "href": "http://stock.jrj.com.cn/2020/10/23173931117311.shtml",
    "datetime": "2020-10-23 17:39:11",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年前三季度净利2.73亿增长160.29% 财务费用下滑",
    "href": "http://stock.jrj.com.cn/2020/10/22202531110750.shtml",
    "datetime": "2020-10-22 20:25:36",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年前三季度净利2.6亿-2.9亿 大力拓展核酸检测业务",
    "href": "http://stock.jrj.com.cn/2020/10/09184431011601.shtml",
    "datetime": "2020-10-09 18:44:29",
    "code": "300639"
  },
  {
    "title": "A股异动 | 凯普生物(300639.SZ)涨10.6% 料第三季度净利同比增147.63%-176.20%",
    "href": "http://stock.jrj.com.cn/2020/10/09100131006194.shtml",
    "datetime": "2020-10-09 10:01:55",
    "code": "300639"
  },
  {
    "title": "凯普生物：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/08193030993661.shtml",
    "datetime": "2020-10-08 19:30:00",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)前三季度净利润预增147.63%-176.2%",
    "href": "http://stock.jrj.com.cn/2020/10/08191430993635.shtml",
    "datetime": "2020-10-08 19:14:20",
    "code": "300639"
  },
  {
    "title": "凯普生物：预计前三季度净利润同比增长147.63%-176.20%",
    "href": "http://stock.jrj.com.cn/2020/10/08171030991995.shtml",
    "datetime": "2020-10-08 17:10:32",
    "code": "300639"
  },
  {
    "title": "凯普生物(300639.SZ)：拟使用不超8亿元暂时闲置募集资金用于购买现金管理产品",
    "href": "http://stock.jrj.com.cn/2020/09/23201030819506.shtml",
    "datetime": "2020-09-23 20:10:45",
    "code": "300639"
  },
  {
    "title": "[凯普生物]火速支援云南防疫工作 凯普生物捐助移动PCR方舱实验室",
    "href": "http://stock.jrj.com.cn/2020/09/18000030777507.shtml",
    "datetime": "2020-09-18 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物荣膺“第14届中国上市公司价值评选”创业板上市公司价值50强",
    "href": "http://stock.jrj.com.cn/2020/09/07000030725253.shtml",
    "datetime": "2020-09-07 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普抗疫先锋再出发 全力以赴支援香港全民检测",
    "href": "http://stock.jrj.com.cn/2020/08/13000030490758.shtml",
    "datetime": "2020-08-13 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年上半年净利1.29亿增长115.43% 医学检验服务收入大幅增长",
    "href": "http://stock.jrj.com.cn/2020/08/07204430451882.shtml",
    "datetime": "2020-08-07 20:44:13",
    "code": "300639"
  },
  {
    "title": "[凯普生物]全力打响新冠病毒歼灭战 不遗余力守护大连安全",
    "href": "http://stock.jrj.com.cn/2020/08/01000030406346.shtml",
    "datetime": "2020-08-01 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物驰援新疆抗疫 高质高效推进核酸检测工作",
    "href": "http://stock.jrj.com.cn/2020/07/28000030364010.shtml",
    "datetime": "2020-07-28 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]粤港澳抗疫一体化 凯普香港分子病理检验中心迅速加入检测战线",
    "href": "http://stock.jrj.com.cn/2020/07/21000030308455.shtml",
    "datetime": "2020-07-21 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]广州凯普医学检验所顺利通过ISO15189现场评审",
    "href": "http://stock.jrj.com.cn/2020/07/20000030296919.shtml",
    "datetime": "2020-07-20 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]无惧骄阳 勇敢“逆行” 凯普北京24小时全力抗疫!",
    "href": "http://stock.jrj.com.cn/2020/06/28000030226027.shtml",
    "datetime": "2020-06-28 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物实控人增持55万股 两大主业稳增助股价涨八成",
    "href": "http://stock.jrj.com.cn/2020/06/22083229986264.shtml",
    "datetime": "2020-06-22 08:32:00",
    "code": "300639"
  },
  {
    "title": "凯普生物股东王建瑜增持55万股 耗资约2228.05万元",
    "href": "http://stock.jrj.com.cn/2020/06/21203329976060.shtml",
    "datetime": "2020-06-21 20:33:36",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物新冠病毒核酸检测试剂列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2020/06/18000030226028.shtml",
    "datetime": "2020-06-18 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物子公司新冠病毒核酸检测试剂盒产品列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2020/06/17184029950766.shtml",
    "datetime": "2020-06-17 18:40:06",
    "code": "300639"
  },
  {
    "title": "【公告解读】凯普生物：子公司新冠病毒核酸检测试剂盒列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2020/06/17173729950380.shtml",
    "datetime": "2020-06-17 17:37:47",
    "code": "300639"
  },
  {
    "title": "凯普生物：子公司新冠病毒核酸检测试剂盒列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2020/06/17170029950008.shtml",
    "datetime": "2020-06-17 17:00:40",
    "code": "300639"
  },
  {
    "title": "[凯普生物]巴西新冠确诊数飙升至全球第二丨凯普生物以科技实力助力抗疫",
    "href": "http://stock.jrj.com.cn/2020/05/29000030226024.shtml",
    "datetime": "2020-05-29 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]众志成城,共抗冠疫 - 凯普生物向智利捐赠抗疫物资",
    "href": "http://stock.jrj.com.cn/2020/05/28000030226025.shtml",
    "datetime": "2020-05-28 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]精准防控 凯普助力武汉“十天大会战”",
    "href": "http://stock.jrj.com.cn/2020/05/25000030226023.shtml",
    "datetime": "2020-05-25 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]“疫”不容辞丨凯普生物携手中华志愿者协会向尼日利亚联邦共和国捐赠抗疫物资",
    "href": "http://stock.jrj.com.cn/2020/05/15000030226033.shtml",
    "datetime": "2020-05-15 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物新冠病毒核酸检测试剂进入商务部出口“白名单”",
    "href": "http://stock.jrj.com.cn/2020/05/05000030226034.shtml",
    "datetime": "2020-05-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]危难时刻,传递“中国温度”- 凯普生物向斯里兰卡捐赠新冠病毒核酸检测试剂盒",
    "href": "http://stock.jrj.com.cn/2020/05/05000030226035.shtml",
    "datetime": "2020-05-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2020年一季度盈利1973.94万 增长15.57% 开展新冠核酸检测业务",
    "href": "http://stock.jrj.com.cn/2020/05/02180329467384.shtml",
    "datetime": "2020-05-02 18:03:13",
    "code": "300639"
  },
  {
    "title": "[凯普生物]巴西中央公共卫生实验室:凯普新冠病毒核酸检测试剂盒快速准确",
    "href": "http://stock.jrj.com.cn/2020/04/22000030226031.shtml",
    "datetime": "2020-04-22 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：2019年净利润同比增长29.11%",
    "href": "http://stock.jrj.com.cn/2020/04/15221229299130.shtml",
    "datetime": "2020-04-15 22:12:00",
    "code": "300639"
  },
  {
    "title": "凯普生物股东云南众合之拟减持637.36万股 预计不超总股本3%",
    "href": "http://stock.jrj.com.cn/2020/04/13215529277273.shtml",
    "datetime": "2020-04-13 21:55:25",
    "code": "300639"
  },
  {
    "title": "凯普生物：股东云南众合之计划减持不超过3%股份",
    "href": "http://stock.jrj.com.cn/2020/04/13205929276936.shtml",
    "datetime": "2020-04-13 20:59:08",
    "code": "300639"
  },
  {
    "title": "凯普生物：股东云南众合之计划减持不超过3%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/13191429276479.shtml",
    "datetime": "2020-04-13 19:14:59",
    "code": "300639"
  },
  {
    "title": "凯普生物：子公司新冠病毒检测产品通过巴西国家卫生监督局认证",
    "href": "http://stock.jrj.com.cn/2020/04/12172529264320.shtml",
    "datetime": "2020-04-12 17:25:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]巴西州长硬核自提凯普新冠核酸检测试剂",
    "href": "http://stock.jrj.com.cn/2020/04/11000030226026.shtml",
    "datetime": "2020-04-11 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]17家凯普检验所全部合格!国家临检中心新冠核酸检测室间质评",
    "href": "http://stock.jrj.com.cn/2020/04/10000030226053.shtml",
    "datetime": "2020-04-10 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]战“疫”担当- 一封来自匈牙利的感谢信,实名点赞凯普生物",
    "href": "http://stock.jrj.com.cn/2020/04/07000030226054.shtml",
    "datetime": "2020-04-07 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物,疫情下的民族企业责任和全球化布局",
    "href": "http://stock.jrj.com.cn/2020/04/03000030226052.shtml",
    "datetime": "2020-04-03 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普战“疫”进行时丨守好关口 不负重托",
    "href": "http://stock.jrj.com.cn/2020/03/23000030226051.shtml",
    "datetime": "2020-03-23 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]【新品上市】凯普葡萄糖-6-磷酸脱氢酶基因检测试剂盒获批上市",
    "href": "http://stock.jrj.com.cn/2020/03/12000030226050.shtml",
    "datetime": "2020-03-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]【新品上市】凯普葡萄糖-6-磷酸脱氢酶基因检测试剂盒获批上市",
    "href": "http://stock.jrj.com.cn/2020/03/12000029018709.shtml",
    "datetime": "2020-03-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物新型冠状病毒2019-nCoV核酸检测试剂盒获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/05000030226049.shtml",
    "datetime": "2020-03-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2019-nCoV核酸检测试剂盒获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/04214628954324.shtml",
    "datetime": "2020-03-04 21:46:13",
    "code": "300639"
  },
  {
    "title": "凯普生物：新型冠状病毒2019-nCoV核酸检测试剂盒获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/04201428953959.shtml",
    "datetime": "2020-03-04 20:14:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物新型冠状病毒2019-nCoV核酸检测试剂盒获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/04000028956120.shtml",
    "datetime": "2020-03-04 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]全部满分!凯普全国多家医学检验所新冠病毒核酸检测室间质评完全通过",
    "href": "http://stock.jrj.com.cn/2020/02/25000030226037.shtml",
    "datetime": "2020-02-25 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：药品磷酸氯喹凝胶开展II期临床试验",
    "href": "http://stock.jrj.com.cn/2020/02/23173328876872.shtml",
    "datetime": "2020-02-23 17:33:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：全资子公司完成新冠病毒COVID-19核酸检测试剂盒开发",
    "href": "http://stock.jrj.com.cn/2020/02/23172528876841.shtml",
    "datetime": "2020-02-23 17:25:54",
    "code": "300639"
  },
  {
    "title": "凯普生物2019年预计净利1.49亿元 同比增长30.24%",
    "href": "http://stock.jrj.com.cn/2020/02/19214728857763.shtml",
    "datetime": "2020-02-19 21:47:31",
    "code": "300639"
  },
  {
    "title": "凯普生物：2019年净利1.49亿元 同比增长30%",
    "href": "http://stock.jrj.com.cn/2020/02/19192628857093.shtml",
    "datetime": "2020-02-19 19:26:46",
    "code": "300639"
  },
  {
    "title": "凯普生物业绩快报：2019年净利同比增30%",
    "href": "http://stock.jrj.com.cn/2020/02/19190728856727.shtml",
    "datetime": "2020-02-19 19:07:00",
    "code": "300639"
  },
  {
    "title": "凯普生物修订定增预案 发行价格打八折",
    "href": "http://stock.jrj.com.cn/2020/02/17202128840956.shtml",
    "datetime": "2020-02-17 20:21:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟定增募资不超10.5亿元 发行价格打8折",
    "href": "http://stock.jrj.com.cn/2020/02/17201728840945.shtml",
    "datetime": "2020-02-17 20:17:27",
    "code": "300639"
  },
  {
    "title": "凯普生物设立公司开展氯喹抑菌消毒产品研制",
    "href": "http://stock.jrj.com.cn/2020/02/14173828830707.shtml",
    "datetime": "2020-02-14 17:38:42",
    "code": "300639"
  },
  {
    "title": "凯普生物：全资子公司投资设立潮州康健 开展氯喹抑菌消毒产品研制",
    "href": "http://stock.jrj.com.cn/2020/02/14163928830379.shtml",
    "datetime": "2020-02-14 16:39:48",
    "code": "300639"
  },
  {
    "title": "凯普生物：设立子公司开展氯喹抑菌消毒产品研制",
    "href": "http://stock.jrj.com.cn/2020/02/14155728830144.shtml",
    "datetime": "2020-02-14 15:57:48",
    "code": "300639"
  },
  {
    "title": "凯普生物：设立公司开展氯喹抑菌消毒产品研制",
    "href": "http://stock.jrj.com.cn/2020/02/14155528830140.shtml",
    "datetime": "2020-02-14 15:55:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟非公开发行募资不超过10.5亿元 深化核酸分子诊断产业",
    "href": "http://stock.jrj.com.cn/2020/02/13211928825732.shtml",
    "datetime": "2020-02-13 21:19:00",
    "code": "300639"
  },
  {
    "title": "凯普生物拟定增募资不超10.5亿元 用于核酸分子诊断产品产业化等项目",
    "href": "http://stock.jrj.com.cn/2020/02/13203828825545.shtml",
    "datetime": "2020-02-13 20:38:17",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟定增募资不超10.5亿元 用于核酸分子诊断产品产业化等项目",
    "href": "http://stock.jrj.com.cn/2020/02/13202328825485.shtml",
    "datetime": "2020-02-13 20:23:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：拟定增募资不超10.5亿元",
    "href": "http://stock.jrj.com.cn/2020/02/13201628825434.shtml",
    "datetime": "2020-02-13 20:16:57",
    "code": "300639"
  },
  {
    "title": "[凯普生物]北京市各级领导指导凯普医学检验所疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/12000028840337.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]北京市各级领导指导凯普医学检验所疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/12000030226040.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]样本检测破万例 疾控专家对凯普新冠病毒检测工作表示肯定",
    "href": "http://stock.jrj.com.cn/2020/02/12000028840334.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]样本检测破万例 疾控专家对凯普新冠病毒检测工作表示肯定",
    "href": "http://stock.jrj.com.cn/2020/02/12000030226041.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]齐心抗疫 祖国一心 - 凯普生物支援香港抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/11000030226038.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]齐心抗疫 祖国一心 | 凯普生物支援香港抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/11000028840335.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "300639"
  },
  {
    "title": "子公司取得医疗器械注册证 研发占比达20% 凯普生物进入高增长期？",
    "href": "http://stock.jrj.com.cn/2020/02/10083328800772.shtml",
    "datetime": "2020-02-10 08:33:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生殖道感染病原体十联检测试剂盒获批上市!",
    "href": "http://stock.jrj.com.cn/2020/02/08000028871294.shtml",
    "datetime": "2020-02-08 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物全资子公司取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/02/07195328794845.shtml",
    "datetime": "2020-02-07 19:53:24",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生殖道感染病原体十联检测试剂盒获批上市!",
    "href": "http://stock.jrj.com.cn/2020/02/07000030226039.shtml",
    "datetime": "2020-02-07 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普为企业复工复产保驾护航!",
    "href": "http://stock.jrj.com.cn/2020/02/05000028840336.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普为企业复工复产保驾护航!",
    "href": "http://stock.jrj.com.cn/2020/02/05000030226036.shtml",
    "datetime": "2020-02-05 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物开发的新型冠状病毒核酸检测试剂盒完成注册抽样工作",
    "href": "http://stock.jrj.com.cn/2020/02/03200028757746.shtml",
    "datetime": "2020-02-03 20:00:57",
    "code": "300639"
  },
  {
    "title": "凯普生物：公司开发的新型冠状病毒核酸检测试剂盒已完成注册抽样工作",
    "href": "http://stock.jrj.com.cn/2020/02/03190928757487.shtml",
    "datetime": "2020-02-03 19:09:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]疫情防控:凯普跑出“战疫”加速度",
    "href": "http://stock.jrj.com.cn/2020/02/02000028777276.shtml",
    "datetime": "2020-02-02 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]疫情防控:凯普跑出“战疫”加速度",
    "href": "http://stock.jrj.com.cn/2020/02/02000030226048.shtml",
    "datetime": "2020-02-02 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]好消息!凯普生物成功完成新型冠状病毒核酸检测试剂盒研制 可用于疑似患者的快速识别鉴定",
    "href": "http://stock.jrj.com.cn/2020/01/31000030226043.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]好消息!凯普生物成功完成新型冠状病毒核酸检测试剂盒研制 可用于疑似患者的快速识别鉴定",
    "href": "http://stock.jrj.com.cn/2020/01/31000028777275.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]南方+ - 潮州这家公司研发出试剂盒,可快速识别鉴定疑似患者",
    "href": "http://stock.jrj.com.cn/2020/01/31000030226046.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]南方+ | 潮州这家公司研发出试剂盒,可快速识别鉴定疑似患者",
    "href": "http://stock.jrj.com.cn/2020/01/31000028777278.shtml",
    "datetime": "2020-01-31 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普春节总动员:全力支持打赢新冠病毒防控攻坚战!",
    "href": "http://stock.jrj.com.cn/2020/01/25000028777277.shtml",
    "datetime": "2020-01-25 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普春节总动员:全力支持打赢新冠病毒防控攻坚战!",
    "href": "http://stock.jrj.com.cn/2020/01/25000030226045.shtml",
    "datetime": "2020-01-25 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]绽放公益梦想丨《新聲》荣获第九届中国公益节“2019年度公益映像奖”",
    "href": "http://stock.jrj.com.cn/2020/01/16000030226044.shtml",
    "datetime": "2020-01-16 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/09152028650059.shtml",
    "datetime": "2020-01-09 15:20:00",
    "code": "300639"
  },
  {
    "title": "凯普生物午后跳水跌6% 业绩不及预期",
    "href": "http://stock.jrj.com.cn/2020/01/09132328649219.shtml",
    "datetime": "2020-01-09 13:23:09",
    "code": "300639"
  },
  {
    "title": "午间公告集锦：凯普生物、康泰生物业绩预增",
    "href": "http://stock.jrj.com.cn/2020/01/09120528649048.shtml",
    "datetime": "2020-01-09 12:05:45",
    "code": "300639"
  },
  {
    "title": "午间公告：康泰生物、凯普生物业绩预增；航锦科技签重要合同",
    "href": "http://stock.jrj.com.cn/2020/01/09120228649047.shtml",
    "datetime": "2020-01-09 12:02:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2019年扣非归母净利预增超三成",
    "href": "http://stock.jrj.com.cn/2020/01/09115828649045.shtml",
    "datetime": "2020-01-09 11:58:44",
    "code": "300639"
  },
  {
    "title": "凯普生物预计2019年实现盈利1.40亿元至1.51亿元 同比增长23%至32%",
    "href": "http://stock.jrj.com.cn/2020/01/09115328649027.shtml",
    "datetime": "2020-01-09 11:53:31",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物荣获“2019粤港澳大湾区上市公司年度新锐奖”",
    "href": "http://stock.jrj.com.cn/2019/12/27000030226042.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物荣获“2019粤港澳大湾区上市公司年度新锐奖”",
    "href": "http://stock.jrj.com.cn/2019/12/27000028703219.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]妇幼十年,凯普相伴|凯普总裁管乔中先生获中国妇幼健康终身荣誉奖",
    "href": "http://stock.jrj.com.cn/2019/11/30000028703223.shtml",
    "datetime": "2019-11-30 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物全资子公司取得医疗器械注册证书",
    "href": "http://stock.jrj.com.cn/2019/11/26090028451011.shtml",
    "datetime": "2019-11-26 09:00:09",
    "code": "300639"
  },
  {
    "title": "[凯普生物]【新品上市】凯普人型支原体/生殖支原体核酸检测试剂盒获三类医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2019/11/25000028703225.shtml",
    "datetime": "2019-11-25 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物荣膺上市公司金牛奖“最具投资价值100强”",
    "href": "http://stock.jrj.com.cn/2019/11/01000028393471.shtml",
    "datetime": "2019-11-01 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]助力妇幼健康-出生缺陷防控交流会",
    "href": "http://stock.jrj.com.cn/2019/10/30000028393472.shtml",
    "datetime": "2019-10-30 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物第三季度盈利4512.29万 同比增长40.02%",
    "href": "http://stock.jrj.com.cn/2019/10/24211728296249.shtml",
    "datetime": "2019-10-24 21:17:45",
    "code": "300639"
  },
  {
    "title": "午间公告:凯普生物子公司获得授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2019/10/23120628287512.shtml",
    "datetime": "2019-10-23 12:06:15",
    "code": "300639"
  },
  {
    "title": "午间公告：凯普生物子公司获得授予发明专利权通知书",
    "href": "http://stock.jrj.com.cn/2019/10/23120028287507.shtml",
    "datetime": "2019-10-23 12:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]合作共赢 凯普生物与欧洲分子基因诊断质量联盟(EMQN)正式达成战略合作",
    "href": "http://stock.jrj.com.cn/2019/10/17000028280080.shtml",
    "datetime": "2019-10-17 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]【上榜】凯普生物当选2019粤港澳大湾区生物科技创新企业50强领军企业",
    "href": "http://stock.jrj.com.cn/2019/10/17000028393476.shtml",
    "datetime": "2019-10-17 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]专科整合 共谋发展 凯普加入华南地区首个妇科疾病防治专科联盟",
    "href": "http://stock.jrj.com.cn/2019/10/15000028391115.shtml",
    "datetime": "2019-10-15 00:00:00",
    "code": "300639"
  },
  {
    "title": "[凯普生物]凯普生物核心技术亮相广东科技创新成果展",
    "href": "http://stock.jrj.com.cn/2019/10/13000028393470.shtml",
    "datetime": "2019-10-13 00:00:00",
    "code": "300639"
  },
  {
    "title": "凯普生物2019年前三季度净利1.01亿元–1.09亿元 不断丰富产品线",
    "href": "http://stock.jrj.com.cn/2019/10/11132928232777.shtml",
    "datetime": "2019-10-11 13:29:02",
    "code": "300639"
  },
  {
    "title": "前三季净利预增28.63%-38.82% 凯普生物涨停",
    "href": "http://stock.jrj.com.cn/2019/10/11102828231890.shtml",
    "datetime": "2019-10-11 10:28:33",
    "code": "300639"
  },
  {
    "title": "凯普生物：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/10212028228837.shtml",
    "datetime": "2019-10-10 21:20:04",
    "code": "300639"
  },
  {
    "title": "凯普生物全资子公司使用闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2019/09/25163628178904.shtml",
    "datetime": "2019-09-25 16:36:58",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升-0.96% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/17093428138714.shtml",
    "datetime": "2019-09-17 09:34:00",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升2.31% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/16094328133420.shtml",
    "datetime": "2019-09-16 09:43:17",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升1.38% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/12102028126059.shtml",
    "datetime": "2019-09-12 10:20:48",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升4.18% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06140628100311.shtml",
    "datetime": "2019-09-06 14:06:44",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升5.57% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06132128100206.shtml",
    "datetime": "2019-09-06 13:21:14",
    "code": "300639"
  },
  {
    "title": "【凯普生物】大幅拉升5.81% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06131628100192.shtml",
    "datetime": "2019-09-06 13:16:13",
    "code": "300639"
  }
]